Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been given an average rating of “Moderate Buy” by the nine ratings firms that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokers that have covered the stock in the last year is $19.75.

OSCR has been the subject of several research analyst reports. Bank of America reiterated a “neutral” rating and set a $21.00 price target (down from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Robert W. Baird started coverage on Oscar Health in a report on Thursday, May 30th. They issued an “outperform” rating and a $28.00 target price for the company. Wells Fargo & Company lifted their price target on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 price objective on shares of Oscar Health in a research note on Wednesday, July 10th. Finally, Baird R W upgraded shares of Oscar Health to a “strong-buy” rating in a report on Thursday, May 30th.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 5,808 shares of the stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $113,023.68. Following the completion of the sale, the insider now owns 65,920 shares of the company’s stock, valued at approximately $1,282,803.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Oscar Health news, insider Mario Schlosser sold 5,808 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total transaction of $113,023.68. Following the sale, the insider now owns 65,920 shares of the company’s stock, valued at $1,282,803.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Victoria Baltrus sold 7,674 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $149,336.04. Following the sale, the chief accounting officer now owns 127,754 shares of the company’s stock, valued at $2,486,092.84. The disclosure for this sale can be found here. Insiders have sold a total of 81,655 shares of company stock valued at $1,589,006 over the last ninety days. 25.11% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Avalon Trust Co bought a new stake in Oscar Health in the first quarter valued at $69,000. Prevail Innovative Wealth Advisors LLC acquired a new position in Oscar Health during the 4th quarter worth approximately $92,000. Farallon Capital Management LLC bought a new position in Oscar Health in the first quarter worth approximately $164,000. Simplicity Wealth LLC acquired a new stake in Oscar Health in the second quarter valued at approximately $179,000. Finally, Cornerstone Investment Partners LLC bought a new stake in shares of Oscar Health during the first quarter valued at approximately $178,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Stock Performance

Oscar Health stock opened at $15.82 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.29. The stock has a market cap of $3.75 billion, a PE ratio of -39.55 and a beta of 1.61. Oscar Health has a 12-month low of $4.72 and a 12-month high of $23.44. The business’s 50-day moving average price is $18.10 and its two-hundred day moving average price is $16.39.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.34. The company had revenue of $2.14 billion for the quarter, compared to analyst estimates of $1.99 billion. Oscar Health had a negative net margin of 0.82% and a negative return on equity of 5.77%. The firm’s revenue was up 45.8% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.18) EPS. As a group, analysts expect that Oscar Health will post -0.06 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.